z-logo
open-access-imgOpen Access
[Corrigendum] Knockdown of mesenchymal stem cell‑derived exosomal LOC100129516 suppresses the symptoms of atherosclerosis via upregulation of the PPARγ/LXRα/ABCA1 signaling pathway
Author(s) -
Limin Sun,
Xin He,
Tao Zhang,
Yu Han,
Tao Gao
Publication year - 2022
Publication title -
international journal of molecular medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.048
H-Index - 90
eISSN - 1791-244X
pISSN - 1107-3756
DOI - 10.3892/ijmm.2022.5106
Subject(s) - gene knockdown , confusion , molecular medicine , oncogene , downregulation and upregulation , destiny (iss module) , cancer research , cell cycle , regret , medicine , apoptosis , cancer , bioinformatics , chemistry , computer science , psychology , biology , physics , biochemistry , psychoanalysis , gene , astronomy , machine learning
During the preparation of the figures in the above article, the authors have realized that errors were introduced during the assembly of Fig. 6. Specifically, the data were shown incorrectly for the H&E experiments shown in the top row for Fig. 6B, and the Oil Red O staining experiments for the Control and AS data panels in Fig. 6B have also been replaced with more representative data; in addition, the second bars in each of the histograms shown in this figure were mislabelled as 'AS': these bars should have been labelled as 'ox-LDL'. The corrected version of Fig. 6 is shown below. These errors did not affect the major conclusions reported in the paper. All the authors have agreed to this Corrigendum, and thank the Editor of International Journal of Molecular Medicine for allowing them the opportunity to publish this. The authors regret these errors went unnoticed before the paper was published, and apologize to the readership for any confusion that it may have caused. [the original article was published in International Journal of Molecular Medicine 48: 208, 2021; DOI: 10.3892/ijmm.2021.5041].

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here